𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Mutations of p53 tumor-suppressor gene in angiosarcoma

✍ Scribed by Norifumi Naka; Yasuhiko Tomita; Hirofumi Nakanishi; Nobuhito Araki; Tadashi Hongyo; Takahiro Ochi; Katsuyuki Aozasa

Publisher
John Wiley and Sons
Year
1997
Tongue
French
Weight
50 KB
Volume
71
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Transgenic mice deficient for the p53 gene were reported to frequently develop angiosarcoma (AS), suggesting that alterations in the gene are associated with tumorigenesis of AS. However, little is known about genetic changes, including p53 gene alterations, in human AS because of its rarity. We analyzed p53 mutations on paraffin-embedded specimens from 33 patients with AS by polymerase chain reaction-singlestrand conformation polymorphism (PCR-SSCP) followed by direct sequencing. Age of patients ranged from 18 to 91 (median 70) years, with a male to female ratio of 1.5:1. Sites of tumor were the head in 13 patients, the trunk in 4, the extremities in 4, the heart in 4, bones in 2 and others in 6. PCR-SSCP revealed aberrant mobility shifts of bands in 17 cases: 11 in exon 5, 5 in exon 7 and 4 in exon 8. Direct sequencing on these 17 cases revealed a total of 20 mutations. The frequency of p53 mutations was different by site of tumors: 7 of 13 in head, all 4 in extremities, 2 of 4 in heart and none of 4 in trunk. Our findings suggest that occurrence of p53 mutation is a major pathway for development of human AS.

πŸ“œ SIMILAR VOLUMES

P53 tumor suppressor gene mutations in h
P53 tumor suppressor gene mutations in hepatocellular carcinoma patients in India
✍ Sanjay Katiyar; Bipin C. Dash; Varsha Thakur; Raj C. Guptan; Shiv K. Sarin; Bhud πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 158 KB πŸ‘ 2 views

BACKGROUND. Specific mutations of the p53 tumor suppressor gene in hepatocellular carcinoma (HCC) have been reported from several parts of the world, but to the authors' knowledge to date the status of this gene has not been studied in HCC patients in India, where HCC is one of the major cancers and

p53 tumor-suppressor gene: Clues to mole
p53 tumor-suppressor gene: Clues to molecular carcinogenesis
✍ Xin W. Wang; Curtis C. Harris πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 207 KB πŸ‘ 1 views

The tumor-suppressor gene product p53 is clearly a component in several biochemical pathways, including transcription, DNA repair, genomic stability, cell-cycle control and apoptosis, that are central to human carcinogenesis. The p53 is functionally inactivated by mutational, viral, and cellular mec

p53 tumor suppressor gene mutations pred
p53 tumor suppressor gene mutations predict decreased survival of patients with sporadic colorectal carcinoma
✍ Morton S. Kahlenberg; Daniel L. Stoler; Miguel A. Rodriguez-Bigas; Thomas K. Web πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 84 KB πŸ‘ 1 views

## Background: Mutations of the p53 tumor suppressor gene play an integral role in sporadic colorectal carcinogenesis but prior studies have failed to show their prognostic significance consistently. ## Methods: Fifty-six consecutive sporadic colorectal tumors were analyzed for their p53 status.